Interaksi Metoprolol dan hidroklorotiazid

Metoprolol dan hidroklorotiazid (Lopressor HCT, Dutoprol), golongan penyekat beta, memiliki 460 interaksi terdokumentasi dalam label FDA dan lembar fakta yang kami indeks: 44 mayor, 355 moderat, 57 minor, dan 4 dengan label yang melaporkan tidak ada interaksi bermakna. Setiap entri di bawah ini mengutip kalimat yang mendasarinya. Halaman obat ini adalah titik awal, bukan putusan untuk situasi Anda.

Interaksi dari label

Interaksi mayor (44)

  • Amiloriddiuretik hemat kaliumMayor

    Hyperkalemia occurs commonly (about 10%) when amiloride is used without a kaliuretic diuretic. (label Amilorid, Peringatan kotak hitam)

  • Arsen trioksidaobat yang memperpanjang interval QTMayor

    The risk of torsade de pointes is related to the extent of QTc prolongation, concomitant administration of QTc prolonging drugs, a history of torsade de pointes, pre-existing QTc interval prolongation, congestive heart failure, administration of potassium-wasting diuretics, or other conditions that result in hypokalemia or hypomagnesemia. (label Arsen trioksida, Peringatan dan perhatian)

  • Asam etakrinatdiuretik loopMayor

    CONTRAINDICATIONS All diuretics, including ethacrynic acid, are contraindicated in anuria. (label Asam etakrinat, Kontraindikasi)

  • Asetazolamidpenghambat karbonat anhidraseMayor

    Anuria Hypersensitivity to metoprolol tartrate or hydrochlorothiazide or to other sulfonamide- derived drugs. (label Metoprolol dan hidroklorotiazid, Kontraindikasi)

  • Lotensin HCT is also contraindicated in patients who are hypersensitive to benazepril, to any other ACE inhibitor, to hydrochlorothiazide, or to other sulfonamide-derived drugs. (label Benazepril dan hidroklorotiazid, Kontraindikasi)

  • Brinzolamidpenghambat karbonat anhidraseMayor

    Anuria Hypersensitivity to metoprolol tartrate or hydrochlorothiazide or to other sulfonamide- derived drugs. (label Metoprolol dan hidroklorotiazid, Kontraindikasi)

  • Bumetaniddiuretik loopMayor

    WARNING Bumetanide is a potent diuretic which, if given in excessive amounts, can lead to a profound diuresis with water and electrolyte depletion. (label Bumetanid, Peringatan kotak hitam)

  • CONTRAINDICATIONS PROGLYCEM is contraindicated in patients with: Functional hypoglycemia Hypersensitivity to diazoxide, any of the excipients in PROGLYCEM, or other thiazides (label Diazoksid, Kontraindikasi)

  • Diklorfenamidpenghambat karbonat anhidraseMayor

    Anuria Hypersensitivity to metoprolol tartrate or hydrochlorothiazide or to other sulfonamide- derived drugs. (label Metoprolol dan hidroklorotiazid, Kontraindikasi)

  • DofetilidantiaritmiaMayor

    The concomitant use of hydrochlorothiazide (alone or in combinations such as with triamterene) with dofetilide is contraindicated (see PRECAUTIONS, Drug-Drug Interactions ) because this has been shown to significantly increase dofetilide plasma concentrations and QT interval prolongation. (label Dofetilid, Kontraindikasi)

  • Dorzolamidpenghambat karbonat anhidraseMayor

    Anuria Hypersensitivity to metoprolol tartrate or hydrochlorothiazide or to other sulfonamide- derived drugs. (label Metoprolol dan hidroklorotiazid, Kontraindikasi)

  • Dorzolamid dan timololpenghambat karbonat anhidraseMayor

    Anuria Hypersensitivity to metoprolol tartrate or hydrochlorothiazide or to other sulfonamide- derived drugs. (label Metoprolol dan hidroklorotiazid, Kontraindikasi)

  • Droperidolantagonis dopaminMayor

    Droperidol should be administered with extreme caution to patients who may be at risk for development of prolonged QT syndrome (e.g., congestive heart failure, bradycardia, use of a diuretic, cardiac hypertrophy, hypokalemia, hypomagnesemia, or administration of other drugs known to increase the QT interval). (label Droperidol, Peringatan kotak hitam)

  • Enalaprilatpenghambat ACEMayor

    …sometimes associated with oliguria and/or progressive azotemia, and rarely with acute renal failure and/or death, include those with the following conditions or characteristics: heart failure, hyponatremia, high dose diuretic therapy, recent intensive diuresis or increase in diuretic dose, renal dialysis, or severe volume and/or salt depletion of any etiology. (label Enalaprilat, Peringatan)

  • Eplerenonantagonis aldosteronMayor

    …• serum creatinine > 2.0 mg/dL in males or >1.8 mg/dL in females, • creatinine clearance < 50 mL/min, or • concomitant administration of potassium supplements or potassium-sparing diuretics (e.g., amiloride, spironolactone, or triamterene) [see Warnings and Precautions (5.1) , Adverse Reactions (6.2) , Drug Interactions (7) , and Clinical Pharmacology (12.3)… (label Eplerenon, Kontraindikasi)

  • EptifibatidantiplateletMayor

    …of active abnormal bleeding within the previous 30 days Severe hypertension (systolic blood pressure >200 mm Hg or diastolic blood pressure >110 mm Hg) not adequately controlled on antihypertensive therapy Major surgery within the preceding 6 weeks History of stroke within 30 days or any history of hemorrhagic stroke Current or planned administration of another… (label Eptifibatid, Kontraindikasi)

  • Feri sitratpengikat fosfatMayor

    …concomitantly with Ferric Citrate Tablets Amlodipine Aspirin Atorvastatin Calcitriol Clopidogrel Digoxin Diltiazem Doxercalciferol Enalapril Fluvastatin Glimepiride Levofloxacin Losartan Metoprolol Pravastatin Propranolol Sitagliptin Warfarin Oral drugs that have to be separated from Ferric Citrate Tablets and meals Dosing Recommendations Doxycycline Take at least 1… (label Feri sitrat, Interaksi obat)

  • FlekainidantiaritmiaMayor

    Concomitant negative chronotropic therapy such as digoxin or beta-blockers may lower the risk of this complication. (label Flekainid, Peringatan kotak hitam)

  • Because the use of diuretics can accentuate the diminished intravascular volume, diuretics should be avoided except in the late phase of resolution as described below. (label Folitropin, Peringatan dan perhatian)

  • GentamisinaminoglikosidaMayor

    The concurrent use of gentamicin with potent diuretics, such as ethacrynic acid or furosemide, should be avoided, since certain diuretics by themselves may cause ototoxicity. (label Gentamisin, Peringatan kotak hitam)

  • Avoid diuretics or laxatives in patients with diarrhea. (label Irinotekan, Peringatan dan perhatian)

  • Itrakonazolantijamur azolMayor

    Diuretics Eplerenone Contraindicated during and 2 weeks after TOLSURA treatment. (label Itrakonazol, Interaksi obat)

  • Kalium sitratsuplemen kaliumMayor

    The following drug interactions may occur with potassium citrate: Potassium-sparing diuretics: concomitant administration should be avoided since the simultaneous administration of these agents can produce severe hyperkalemia (7.1) (label Kalium sitrat, Interaksi obat)

  • KlozapinantipsikotikMayor

    Use CLOZARIL cautiously in patients with cardiovascular or cerebrovascular disease or conditions predisposing to hypotension (e.g., dehydration, use of antihypertensive medications) [see Dosage and Administration ( 2.2 , 2.6 ), Warnings and Precautions ( 5.2 )]. (label Klozapin, Peringatan kotak hitam)

  • Because the use of diuretics can accentuate the diminished intravascular volume, avoid diuretics except in the late phase of resolution. (label Koriogonadotropin alfa, Peringatan)

  • Kuinaprilpenghambat ACEMayor

    …sometimes associated with oliguria and/or progressive azotemia, and rarely with acute renal failure and/or death, include patients with the following conditions or characteristics: heart failure, hyponatremia, high dose diuretic therapy, recent intensive diuresis or increase in diuretic dose, renal dialysis, or severe volume and/or salt depletion of any etiology. (label Kuinapril, Peringatan)

  • Metazolamidpenghambat karbonat anhidraseMayor

    Anuria Hypersensitivity to metoprolol tartrate or hydrochlorothiazide or to other sulfonamide- derived drugs. (label Metoprolol dan hidroklorotiazid, Kontraindikasi)

  • In addition, life-threatening arrhythmias may occur during anesthesia and surgery, and may require treatment with a beta-blocker or lidocaine. (label Metirosin, Peringatan)

  • Metolazondiuretik tiazidMayor

    Other Antihypertensive Drugs When metolazone tablets, USP, are used with other antihypertensive drugs, particular care must be taken to avoid excessive reduction of blood pressure, especially during initial therapy. (label Metolazon, Peringatan)

  • MinoksidilvasodilatorMayor

    Minoxidil should be reserved for hypertensive patients who do not respond adequately to maximum therapeutic doses of a diuretic and two other antihypertensive agents. (label Minoksidil, Peringatan kotak hitam)

  • Natrium bikarbonatantasidaMayor

    Sodium bicarbonate injection is contraindicated in patients who are losing chloride by vomiting or from continuous gastrointestinal suction and in patients receiving diuretics known to produce a hypochloremic alkalosis. (label Natrium bikarbonat, Kontraindikasi)

  • Nebivololpenyekat betaMayor

    Hypotensive Agents Do not use BYSTOLIC with other β-blockers. (label Nebivolol, Interaksi obat)

  • NeomisinaminoglikosidaMayor

    The concurrent use of neomycin with potent diuretics such as ethacrynic acid or furosemide should be avoided, since certain diuretics by themselves may cause ototoxicity. (label Neomisin, Peringatan kotak hitam)

  • Perak sulfadiazinsulfonamidaMayor

    Anuria Hypersensitivity to metoprolol tartrate or hydrochlorothiazide or to other sulfonamide- derived drugs. (label Metoprolol dan hidroklorotiazid, Kontraindikasi)

  • Risk factors include high dose or overdose, rapid administration (see WARNINGS and DOSAGE AND ADMINISTRATION ), repeated doses, previous administration of protamine, and current or previous use of protamine-containing drugs (NPH insulin, protamine zinc insulin, and certain beta-blockers). (label Protamin, Peringatan kotak hitam)

  • RepaglinidmeglitinidMayor

    Examples: beta-blockers, clonidine, guanethidine, and reserpine Clopidogrel : Avoid concomitant use; if used concomitantly initiate at 0.5 mg before each meal and limit total daily dose to 4 mg ( 7 ) (label Repaglinid, Interaksi obat)

  • Rivastigminpenghambat kolinesteraseMayor

    Concomitant use with metoclopramide, beta-blockers, or cholinomimetic and anticholinergic drugs is not recommended ( 7.1 , 7.2 , 7.3 ) (label Rivastigmin, Interaksi obat)

  • SiklosporinimunosupresanMayor

    Potassium-Sparing Diuretics Cyclosporine should not be used with potassium-sparing diuretics because hyperkalemia can occur. (label Siklosporin, Interaksi obat)

  • SulfadiazinsulfonamidaMayor

    Anuria Hypersensitivity to metoprolol tartrate or hydrochlorothiazide or to other sulfonamide- derived drugs. (label Metoprolol dan hidroklorotiazid, Kontraindikasi)

  • Anuria Hypersensitivity to metoprolol tartrate or hydrochlorothiazide or to other sulfonamide- derived drugs. (label Metoprolol dan hidroklorotiazid, Kontraindikasi)

  • SulfasalazinsulfonamidaMayor

    Anuria Hypersensitivity to metoprolol tartrate or hydrochlorothiazide or to other sulfonamide- derived drugs. (label Metoprolol dan hidroklorotiazid, Kontraindikasi)

  • Tadalafilpenghambat PDE5Mayor

    …coadministration of an alpha-blocker and CIALIS for the treatment of BPH has not been adequately studied, and due to the potential vasodilatory effects of combined use resulting in blood pressure lowering, the combination of CIALIS and alpha-blockers is not recommended for the treatment of BPH. [see Dosage and Administration ( 2.7 ), Drug Interactions ( 7.1 ),… (label Tadalafil, Peringatan dan perhatian)

  • Tranilsiprominpenghambat MAOMayor

    …Syndrome (SS) c ] Agents with blood pressure-reducing effects Use with caution d Hypotension e Non-selective H1 receptor antagonists Contraindicated a Increased anticholinergic effects Beta-adrenergic blockers (see also agents or procedures with blood pressure-reducing effects) Use with the caution d More pronounced bradycardia, postural hypotension e Blood glucose-lowering… (label Tranilsipromin, Interaksi obat)

  • ZonisamidantikonvulsanMayor

    Anuria Hypersensitivity to metoprolol tartrate or hydrochlorothiazide or to other sulfonamide- derived drugs. (label Metoprolol dan hidroklorotiazid, Kontraindikasi)

Interaksi moderat (355)

  • Abirateronpenghambat CYP2D6Moderat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • AkarbosaantidiabetesModerat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • AklidiniumantikolinergikModerat

    Because beta1-selectivity is not absolute, use the lowest possible dose of metoprolol tartrate and have bronchodilators (e.g., beta 2 -agonists) readily available or administered concomitantly . (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Alfuzosinpenyekat alfaModerat

    Postural hypotension/syncope: Care should be taken in patients with symptomatic hypotension or who have had a hypotensive response to other medications or are concomitantly treated with antihypertensive medication or nitrates ( 5.1 ) (label Alfuzosin, Peringatan dan perhatian)

  • AliskirenantihipertensiModerat

    Risk factors for the development of hyperkalemia include renal insufficiency, diabetes, combination use with ARBs or ACEIs [see Contraindications ( 4 ), Warnings and Precautions ( 5.2 ), and Clinical Studies ( 14.3 )] , NSAIDs, or potassium supplements or potassium sparing diuretics. (label Aliskiren, Peringatan dan perhatian)

  • Alogliptinpenghambat DPP-4Moderat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Alogliptin dan metforminpenghambat DPP-4Moderat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Alopurinolpenghambat xantin oksidaseModerat

    Hypersensitivity reactions to allopurinol tablets may be increased in patients with decreased kidney function receiving thiazide diuretics and allopurinol tablets concurrently. (label Alopurinol, Peringatan dan perhatian)

  • AmikasinaminoglikosidaModerat

    Ethacrynic Acid, Furosemide, Urea, or Mannitol Some diuretics can enhance aminoglycoside toxicity by altering aminoglycoside concentrations in serum and tissue. (label Amikasin, Interaksi obat)

  • AminofilinmetilxantinModerat

    Because beta1-selectivity is not absolute, use the lowest possible dose of metoprolol tartrate and have bronchodilators (e.g., beta 2 -agonists) readily available or administered concomitantly . (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • AmiodaronantiaritmiaModerat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Amlodipinpenghambat kanal kalsium dihidropiridinModerat

    Digitalis, Clonidine, and Calcium Channel Blockers: Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Amlodipin dan atorvastatinpenghambat kanal kalsium dihidropiridinModerat

    Digitalis, Clonidine, and Calcium Channel Blockers: Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Amlodipin dan benazeprilpenghambat kanal kalsium dihidropiridinModerat

    Digitalis, Clonidine, and Calcium Channel Blockers: Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Amlodipin dan olmesartanpenghambat kanal kalsium dihidropiridinModerat

    Digitalis, Clonidine, and Calcium Channel Blockers: Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Amlodipin dan valsartanpenghambat kanal kalsium dihidropiridinModerat

    Digitalis, Clonidine, and Calcium Channel Blockers: Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Amoksisilinantibiotik penisilinModerat

    Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Amoksisilin dan klavulanatantibiotik penisilinModerat

    Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Ampisilinantibiotik penisilinModerat

    Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Ampisilin dan sulbaktamantibiotik penisilinModerat

    Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Arformoterolagonis beta-adrenergikModerat

    Because beta1-selectivity is not absolute, use the lowest possible dose of metoprolol tartrate and have bronchodilators (e.g., beta 2 -agonists) readily available or administered concomitantly . (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • AripiprazolantipsikotikModerat

    Antihypertensive Drugs Due to its alpha-adrenergic antagonism, aripiprazole has the potential to enhance the effect of certain antihypertensive agents. (label Aripiprazol, Interaksi obat)

  • Armodafinilstimulan SSPModerat

    There was also a slightly greater proportion of patients on NUVIGIL requiring new or increased use of antihypertensive medications (2.9%) compared to patients on placebo (1.8%). (label Armodafinil, Peringatan dan perhatian)

  • Artikain dan epinefrinanestetik lokalModerat

    Patients may be unresponsive to the usual doses of epinephrine used to treat allergic reaction. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Asam mefenamatOAINSModerat

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Asam zoledronatbisfosfonatModerat

    Elderly patients and those receiving diuretic therapy are at increased risk of acute renal failure. (label Asam zoledronat, Peringatan dan perhatian)

  • Asebutololpenyekat betaModerat

    Although β-blockers should be avoided in overt cardiac failure, acebutolol can be used with caution in patients with a history of heart failure who are controlled with digitalis and/or diuretics. (label Asebutolol, Peringatan)

  • AsenapinantipsikotikModerat

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (elderly patients, patients with dehydration, hypovolemia, concomitant treatment with antihypertensive medications, patients with known cardiovascular disease (history of myocardial infarction or ischemic heart disease, heart failure, or conduction abnormalities), and patients… (label Asenapin, Peringatan dan perhatian)

  • AspirinOAINSModerat

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Aspirin dan dipiridamolantiplateletModerat

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Atenololpenyekat betaModerat

    Because of its relative beta 1 selectivity, however, TENORMIN may be used with caution in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. (label Atenolol, Peringatan)

  • Atenolol dan klortalidonpenyekat betaModerat

    Because of its relative beta 1 -selectivity, however, atenolol and chlorthalidone may be used with caution in patients with bronchospastic disease who do not respond to or cannot tolerate, other antihypertensive treatment. (label Atenolol dan klortalidon, Peringatan)

  • Atomoksetinpenghambat ambilan kembali norepinefrinModerat

    Antihypertensive Drugs Prevention or Management Increase the frequency of monitoring blood pressure and adjust atomoxetine oral solution dosage as clinically appropriate. (label Atomoksetin, Interaksi obat)

  • Avanafilpenghambat PDE5Moderat

    • Use of avanafil with alpha-blockers, other antihypertensives, or substantial amounts of alcohol (greater than 3 units) may lead to hypotension ( 2.3 , 5.6 , 5.7 ) (label Avanafil, Peringatan dan perhatian)

  • Azilsartanpenghambat reseptor angiotensin II (ARB)Moderat

    Hypotension in Volume- or Salt-Depleted Patients In patients with an activated renin-angiotensin system, such as volume- and/or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may occur after initiation of treatment with azilsartan medoxomil. (label Azilsartan, Peringatan dan perhatian)

  • Beksagliflozinpenghambat SGLT2Moderat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Beladona dan opiumopioidModerat

    Diuretics Clinical Impact : Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (label Beladona dan opium, Interaksi obat)

  • Benazeprilpenghambat ACEModerat

    Patients at risk of excessive hypotension include those with the following conditions or characteristics: heart failure with systolic blood pressure below 100 mm Hg, ischemic heart disease, cerebrovascular disease, hyponatremia, high dose diuretic therapy, renal dialysis, or severe volume and/or salt depletion of any etiology. (label Benazepril, Peringatan dan perhatian)

  • Benzfetaminstimulan SSPModerat

    Amphetamines may decrease the hypotensive effect of antihypertensives. (label Benzfetamin, Interaksi obat)

  • Benzilpenisilin (penisilin G)antibiotik penisilinModerat

    Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Bisoprololpenyekat betaModerat

    Because of its relative beta 1 -selectivity, however, BISOPROLOL FUMARATE may be used with caution in patients with bronchospastic disease who do not respond to, or who cannot tolerate other antihypertensive treatment. (label Bisoprolol, Peringatan)

  • Because of the relative beta 1 -selectivity of bisoprolol fumarate, bisoprolol fumarate and hydrochlorothiazide tablets may be used with caution in patients with bronchospastic disease who do not respond to, or who cannot tolerate other antihypertensive treatment. (label Bisoprolol dan hidroklorotiazid, Peringatan)

  • BortezomibModerat

    Hypotension: Use caution when treating patients taking antihypertensives, with a history of syncope, or with dehydration. (label Bortezomib, Peringatan dan perhatian)

  • BrekspiprazolantipsikotikModerat

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (e.g., elderly patients, patients with dehydration, hypovolemia, concomitant treatment with antihypertensive medication), patients with known cardiovascular disease (history of myocardial infarction, ischemic heart disease, heart failure, or conduction abnormalities), and… (label Brekspiprazol, Peringatan dan perhatian)

  • Brimonidinagonis alfa-adrenergikModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate ophthalmic solution 0.1% and 0.15% may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate ophthalmic solution 0.1% and 0.15% is advised. (label Brimonidin, Interaksi obat)

  • Brimonidin dan timololagonis alfa-adrenergikModerat

    Antihypertensives/Cardiac Glycosides Because brimonidine tartrate/timolol maleate ophthalmic solution may reduce blood pressure, caution in using drugs such as antihypertensives and/or cardiac glycosides with brimonidine tartrate/timolol maleate ophthalmic solution is advised. (label Brimonidin dan timolol, Interaksi obat)

  • Central Nervous System (CNS) depressants Antihistamines have additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, antianxiety agents, etc.). Antihypertensive drugs Sympathomimetic may reduce the effects of antihypertensive drugs. (label Bromfeniramin, pseudoefedrin, dan dekstrometorfan, Interaksi obat)

  • Bromokriptinagonis dopaminModerat

    Use caution in patients taking antihypertensive medications. (label Bromokriptin, Peringatan dan perhatian)

  • Budesonid dan formoterolkortikosteroidModerat

    Because beta1-selectivity is not absolute, use the lowest possible dose of metoprolol tartrate and have bronchodilators (e.g., beta 2 -agonists) readily available or administered concomitantly . (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Bupivakainanestetik lokalModerat

    Risk of Hypertension and Bradycardia Due to Drug Interactions Between MARCAINE WITH EPINEPHRINE and Nonselective Beta-Adrenergic Antagonists Administration of MARCAINE WITH EPINEPHRINE (containing a vasoconstrictor) in patients receiving nonselective beta-adrenergic antagonists may cause severe hypertension and bradycardia. (label Bupivakain, Peringatan dan perhatian)

  • Bupivakain dan epinefrinanestetik lokalModerat

    Patients may be unresponsive to the usual doses of epinephrine used to treat allergic reaction. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • BuprenorfinopioidModerat

    Examples: cyclobenzaprine, metaxalone Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (label Buprenorfin, Interaksi obat)

  • Examples: Cyclobenzaprine, metaxalone Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (label Buprenorfin dan nalokson, Interaksi obat)

  • BupropionantidepresanModerat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Examples: cyclobenzaprine, metaxalone Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (label Butalbital, parasetamol, kafein, dan kodein, Interaksi obat)

  • Dapagliflozinpenghambat SGLT2Moderat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Dapagliflozin dan metforminpenghambat SGLT2Moderat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • DarifenasinantikolinergikModerat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • DarunavirantiretroviralModerat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Darunavir dan kobisistatantiretroviralModerat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Dekslansoprazolpenghambat pompa protonModerat

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions (6.2) ] . (label Dekslansoprazol, Peringatan dan perhatian)

  • Deksmetilfenidatstimulan SSPModerat

    • Antihypertensive Drugs: Monitor blood pressure. (label Deksmetilfenidat, Interaksi obat)

  • Dekstrometorfan dan kuinidinobat serotonergikModerat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Desipraminantidepresan trisiklikModerat

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia with NORPRAMIN. (label Desipramin, Peringatan)

  • …Hyponatremia Concomitant administration of DESMODA with other drugs that may increase the risk of water intoxication with hyponatremia, (e.g., tricyclic antidepressants, selective serotonin re-uptake inhibitors, chlorpromazine, opiate analgesics, thiazide diuretics, NSAIDs, lamotrigine, sulfonylureas, particularly chlorpropamide, oxybutynin and carbamazepine). (label Desmopresin, Interaksi obat)

  • DesvenlafaksinSNRIModerat

    Also, patients taking diuretics or who are otherwise volume depleted can be at greater risk [see Use in Specific Populations (8.5) and Clinical Pharmacology (12.3) ] . (label Desvenlafaksin, Peringatan dan perhatian)

  • Deutetrabenazinpenghambat VMAT2Moderat

    Drug Interactions with Metoprolol Catecholamine Depleting Drugs: The concomitant use of catecholamine-depleting drugs (e.g., reserpine, monoamine oxidase (MAO) inhibitors) with beta adrenergic blockers may have an additive affect and increase the risk of hypotension or bradycardia CYP2D6 Inhibitors: Drugs that are strong inhibitors of CYP2D6 such as quinidine,… (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Dietilpropionstimulan SSPModerat

    The pressor effects of diethylpropion and those of other drugs may be additive when the drugs are used concomitantly; conversely, diethylpropion may interfere with antihypertensive drugs (i.e., guanethidine, a-methyldopa). (label Dietilpropion, Interaksi obat)

  • DifenhidraminantihistaminModerat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • DiflunisalOAINSModerat

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Digoksinglikosida digitalisModerat

    Digitalis, Clonidine, and Calcium Channel Blockers: Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Dihidroergotaminalkaloid ergotModerat

    Beta Blockers Although the results of a clinical study did not indicate a safety problem associated with the administration of Dihydroergotamine Mesylate Injection, USP to subjects already receiving propranolol, there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine. (label Dihidroergotamin, Interaksi obat)

  • DiklofenakOAINSModerat

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Dikloksasilinantibiotik penisilinModerat

    Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Diltiazempenghambat kanal kalsiumModerat

    Digitalis, Clonidine, and Calcium Channel Blockers: Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Dokserkalsiferolanalog vitamin DModerat

    Risk may be increased when used concomitantly with high dose calcium preparations, thiazide diuretics, or vitamin D compounds. (label Dokserkalsiferol, Peringatan dan perhatian)

  • DronedaronantiaritmiaModerat

    Give a low dose of beta-blockers initially, and increase only after ECG verification of good tolerability [see Drug Interactions (7.3) , Clinical Pharmacology (12.3) ] . (label Dronedaron, Interaksi obat)

  • Drospirenon dan etinilestradiolkontrasepsi oralModerat

    Medications that may increase serum potassium concentration include ACE inhibitors, angiotensin-II receptor antagonists, potassium-sparing diuretics, potassium supplementation, heparin, aldosterone antagonists, and NSAIDS. (label Drospirenon dan etinilestradiol, Peringatan dan perhatian)

  • Dulaglutidagonis reseptor GLP-1Moderat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • DuloksetinSNRIModerat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Eksenatidagonis reseptor GLP-1Moderat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Empagliflozinpenghambat SGLT2Moderat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Empagliflozin dan metforminpenghambat SGLT2Moderat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Enalaprilpenghambat ACEModerat

    Patients at risk of excessive hypotension include those with the following conditions or characteristics: heart failure with systolic blood pressure below 100 mmHg, ischemic heart disease, cerebrovascular disease, hyponatremia, high dose diuretic therapy, renal dialysis, or severe volume and/or salt depletion of any etiology. (label Enalapril, Peringatan dan perhatian)

  • EpinefrinsimpatomimetikModerat

    Patients may be unresponsive to the usual doses of epinephrine used to treat allergic reaction. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Following initiation and titration of Epogen, approximately 25% of patients on dialysis required initiation of or increases in antihypertensive therapy; hypertensive encephalopathy and seizures have been reported in patients with CKD receiving Epogen. (label Epoetin alfa, Peringatan dan perhatian)

  • Epoprostenolanalog prostaglandinModerat

    Additional reductions in blood pressure may occur when VELETRI is administered with diuretics, antihypertensive agents, or other vasodilators. (label Epoprostenol, Interaksi obat)

  • Ergotamin dan kafeinalkaloid ergotModerat

    The beta-blocker Inderal (propranolol) has been reported to potentiate the vasoconstrictive action of ergotamine tartrate and caffeine tablets by blocking the vasodilating property of epinephrine. (label Ergotamin dan kafein, Interaksi obat)

  • EsitalopramSSRIModerat

    Also, patients taking diuretics or who are otherwise volume depleted may be at greater risk. (label Esitalopram, Peringatan dan perhatian)

  • Esmololpenyekat betaModerat

    Antihypertensive agents clonidine, guanfacine, or moxonidine: Beta blockers also increase the risk of clonidine-, guanfacine-, or moxonidine-withdrawal rebound hypertension. (label Esmolol, Interaksi obat)

  • Esomeprazolpenghambat pompa protonModerat

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions (6.2) ] . (label Esomeprazol, Peringatan dan perhatian)

  • EtodolakOAINSModerat

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • EverolimusimunosupresanModerat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Felodipinpenghambat kanal kalsium dihidropiridinModerat

    Digitalis, Clonidine, and Calcium Channel Blockers: Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Fenelzinpenghambat MAOModerat

    Catecholamine-depleting drugs (e.g., MAO inhibitors): Hypotension, bradycardia. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Fenoksimetilpenisilin (penisilin V)antibiotik penisilinModerat

    Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • FenoprofenOAINSModerat

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • FentanilopioidModerat

    …treatment with Class 1 and Class III antiarrhythmics, 4) treatment with monoamine oxidase inhibitors (MAOI's), 5) concomitant treatment with other drug products known to prolong the QT interval and 6) electrolyte imbalance, in particular hypokalemia and hypomagnesemia, or concomitant treatment with drugs (e.g., diuretics) that may cause electrolyte imbalance. (label Fentanil, Peringatan dan perhatian)

  • Fentermin dan topiramatstimulan SSPModerat

    Concomitant administration of hydrochlorothiazide alone with topiramate alone has been shown to increase the C max and AUC of topiramate by 27% and 29%, respectively. (label Fentermin dan topiramat, Interaksi obat)

  • FludrokortisonkortikosteroidModerat

    Amphotericin B or potassium-depleting diuretics (benzothiadiazines and related drugs, ethacrynic acid and furosemide)—enhanced hypokalemia. (label Fludrokortison, Interaksi obat)

  • Flukonazolantijamur azolModerat

    Hydrochlorothiazide In a pharmacokinetic interaction study, coadministration of multiple-dose hydrochlorothiazide to healthy volunteers receiving fluconazole increased plasma concentrations of fluconazole by 40%. (label Flukonazol, Interaksi obat)

  • FluoksetinSSRIModerat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • FlurbiprofenOAINSModerat

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Flutikason dan salmeterolkortikosteroidModerat

    Because beta1-selectivity is not absolute, use the lowest possible dose of metoprolol tartrate and have bronchodilators (e.g., beta 2 -agonists) readily available or administered concomitantly . (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • FluvoksaminSSRIModerat

    Propranolol or metoprolol : Reduce dose if coadministered and titrate more cautiously ( 7.3 ). (label Fluvoksamin, Interaksi obat)

  • Formoterolagonis beta-adrenergikModerat

    Because beta1-selectivity is not absolute, use the lowest possible dose of metoprolol tartrate and have bronchodilators (e.g., beta 2 -agonists) readily available or administered concomitantly . (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Fosinoprilpenghambat ACEModerat

    In separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone, nifedipine, propranolol, hydrochlorothiazide, cimetidine, metoclopramide, propantheline, digoxin, and warfarin, the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs. (label Fosinopril, Interaksi obat)

  • Fosinopril dan hidroklorotiazidpenghambat ACEModerat

    The thiazide component of fosinopril sodium and hydrochlorothiazide may potentiate the action of other antihypertensive drugs, especially ganglionic or peripheral adrenergic-blocking drugs. (label Fosinopril dan hidroklorotiazid, Peringatan)

  • FoskarnetantivirusModerat

    When diuretics are indicated, thiazides are recommended over loop diuretics because the latter inhibit renal tubular secretion, and may impair elimination of FOSCAVIR, potentially leading to toxicity. (label Foskarnet, Interaksi obat)

  • Furosemiddiuretik loopModerat

    If such symptoms occur, increase diuretics and restore clinical stability before advancing the dose of metoprolol. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • GlibenklamidsulfonilureaModerat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Glibenklamid dan metforminsulfonilureaModerat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • GlimepiridsulfonilureaModerat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • GlipizidsulfonilureaModerat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Glipizid dan metforminsulfonilureaModerat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • GlukagonModerat

    Table 4: Clinically Significant Drug Interaction with GVOKE and GVOKE VialDx Beta-Blockers Clincial Impact: Patients taking beta-blockers may have a transient increase in pulse and blood pressure when given GVOKE or GVOKE VialDx. (label Glukagon, Interaksi obat)

  • HaloperidolantipsikotikModerat

    Caution is advised when haloperidol decanoate is used in combination with drugs known to cause electrolyte imbalance (e.g., diuretics or corticosteroids) because hypokalemia, hypomagnesemia, and hypocalcemia are risk factors for QT prolongation. (label Haloperidol, Interaksi obat)

  • HidrokodonopioidModerat

    Example: Cyclobenzaprine, metaxalone Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (label Hidrokodon, Interaksi obat)

  • Diuretics : Hydrocodone may reduce the efficacy of diuretics. (label Hidrokodon dan homatropin, Interaksi obat)

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Diuretics : Hydrocodone may reduce the efficacy of diuretics. (label Hidrokodon dan klorfeniramin, Interaksi obat)

  • Diuretics Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (label Hidrokodon dan parasetamol, Interaksi obat)

  • HidromorfonopioidModerat

    Examples: cyclobenzaprine, metaxalone Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (label Hidromorfon, Interaksi obat)

  • IbuprofenOAINSModerat

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • IloperidonantipsikotikModerat

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (e.g., elderly patients, patients with dehydration, hypovolemia, and concomitant treatment with antihypertensive medications), patients with known cardiovascular disease (history of myocardial infarction, ischemic heart disease, heart failure, or conduction abnormalities), and… (label Iloperidon, Peringatan dan perhatian)

  • Imatinibpenghambat CYP3A4Moderat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Imipraminantidepresan trisiklikModerat

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia with imipramine hydrochloride tablets. (label Imipramin, Peringatan)

  • Indapamiddiuretik tiazidModerat

    Drug Interactions Other Antihypertensives: Indapamide may add to or potentiate the action of other antihypertensive drugs. (label Indapamid, Interaksi obat)

  • IndometasinOAINSModerat

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Insulin aspartinsulinModerat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Insulin degludekinsulinModerat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Insulin detemirinsulinModerat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Insulin glargininsulinModerat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Insulin lisproinsulinModerat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • IpratropiumantikolinergikModerat

    Because beta1-selectivity is not absolute, use the lowest possible dose of metoprolol tartrate and have bronchodilators (e.g., beta 2 -agonists) readily available or administered concomitantly . (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Ipratropium dan salbutamolantikolinergikModerat

    Because beta1-selectivity is not absolute, use the lowest possible dose of metoprolol tartrate and have bronchodilators (e.g., beta 2 -agonists) readily available or administered concomitantly . (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Irbesartanpenghambat reseptor angiotensin II (ARB)Moderat

    Hypotension in Volume or Salt-Depleted Patients In patients with an activated renin-angiotensin system, such as volume or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may occur after initialization of treatment with AVAPRO. (label Irbesartan, Peringatan dan perhatian)

  • Isoflurananestetik umumModerat

    Concomitant Use with Beta Blockers Concomitant use of beta blockers may exaggerate the cardiovascular effects of inhalational anesthetics, including hypotension and negative inotropic effects. (label Isofluran, Interaksi obat)

  • IsoniazidantibiotikModerat

    Catecholamine-depleting drugs (e.g., MAO inhibitors): Hypotension, bradycardia. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Isoprenalinagonis beta-adrenergikModerat

    Because beta1-selectivity is not absolute, use the lowest possible dose of metoprolol tartrate and have bronchodilators (e.g., beta 2 -agonists) readily available or administered concomitantly . (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Isradipinpenghambat kanal kalsium dihidropiridinModerat

    Digitalis, Clonidine, and Calcium Channel Blockers: Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • IvabradinModerat

    The risk of bradycardia increases with concomitant administration of drugs that slow heart rate (e.g., digoxin, amiodarone, beta-blockers). (label Ivabradin, Interaksi obat)

  • Concurrent use with potassium-containing medications, potassium-sparing diuretics and angiotensin-converting enzyme inhibitors (ACE inhibitors) may result in hyperkalemia and cardiac arrhythmias or cardiac arrest. (label Kalium iodida, Interaksi obat)

  • Kalsitriolanalog vitamin DModerat

    Thiazides Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine. (label Kalsitriol, Interaksi obat)

  • Drugs That Increase the Risk of Hypercalcemia Increase frequency of monitoring of calcium concentrations in patients taking concomitant Calcium Chloride Injection and other drugs that increase the risk of hypercalcemia (e.g., calcipotriene, estrogen, lithium, parathyroid hormone, teriparatide, thiazide diuretics, Vitamin A, and Vitamin D). (label Kalsium klorida, Interaksi obat)

  • Kanagliflozinpenghambat SGLT2Moderat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Kandesartanpenghambat reseptor angiotensin II (ARB)Moderat

    Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (label Kandesartan, Peringatan dan perhatian)

  • Kaptoprilpenghambat ACEModerat

    Hypotension Excessive hypotension was rarely seen in hypertensive patients but is a possible consequence of captopril use in salt/volume depleted persons (such as those treated vigorously with diuretics), patients with heart failure or those patients undergoing renal dialysis (see PRECAUTIONS : Drug Interactions ). (label Kaptopril, Peringatan)

  • KarbamazepinantikonvulsanModerat

    Elderly patients and patients treated with diuretics are at greater risk of developing hyponatremia. (label Karbamazepin, Peringatan dan perhatian)

  • KarbidopaModerat

    Symptomatic postural hypotension has occurred when carbidopa, given with levodopa or carbidopa-levodopa combination products, was added to the treatment of a patient receiving antihypertensive drugs. (label Karbidopa, Interaksi obat)

  • Karbidopa dan levodopaobat dopaminergikModerat

    Antihypertensive drugs: May cause symptomatic postural hypotension. (label Karbidopa dan levodopa, Interaksi obat)

  • Karbidopa, levodopa, dan entakaponobat dopaminergikModerat

    Antihypertensive Agents Symptomatic postural hypotension has occurred when carbidopa/levodopa was added to the treatment of patients receiving antihypertensive drugs. (label Karbidopa, levodopa, dan entakapon, Interaksi obat)

  • KariprazinantipsikotikModerat

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (e.g., elderly patients, patients with dehydration, hypovolemia, and concomitant treatment with antihypertensive medications), patients with known cardiovascular disease (history of myocardial infarction, ischemic heart disease, heart failure, or conduction abnormalities), and… (label Kariprazin, Peringatan dan perhatian)

  • Karvedilolpenyekat betaModerat

    If such symptoms occur, diuretics should be increased and the carvedilol dose should not be advanced until clinical stability resumes [see Dosage and Administration (2) ] . (label Karvedilol, Peringatan dan perhatian)

  • Ketokonazolantijamur azolModerat

    Antivirals indinavir, maraviroc, saquinavir Beta Blockers nadolol Calcium Channel Blockers felodipine, nisoldipine other dihydropyridines, verapamil Calcium channel blockers can have a negative inotropic effect which may be additive to those of ketoconazole. (label Ketokonazol, Interaksi obat)

  • KetoprofenOAINSModerat

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • KetorolakOAINSModerat

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • KlobazambenzodiazepinModerat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • KlofarabinantimetabolitModerat

    Consider use of diuretics and/or albumin. (label Klofarabin, Peringatan dan perhatian)

  • Klonidinagonis alfa-adrenergikModerat

    Digitalis, Clonidine, and Calcium Channel Blockers: Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Klorotiaziddiuretik tiazidModerat

    Thiazides may add to or potentiate the action of other antihypertensive drugs. (label Klorotiazid, Peringatan)

  • KlorpromazinantipsikotikModerat

    Thiazide diuretics may accentuate the orthostatic hypotension that may occur with phenothiazines. (label Klorpromazin, Perhatian)

  • Klortalidondiuretik tiazidModerat

    Effect of chlorthalidone on other drugs Chlorthalidone may add to or potentiate the action of other antihypertensive drugs. (label Klortalidon, Interaksi obat)

  • KodeinopioidModerat

    Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (label Kodein, Interaksi obat)

  • Kolestipolsekuestran asam empeduModerat

    Cholestyramine and colestipol: Reduced absorption of thiazides. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Kolestiraminsekuestran asam empeduModerat

    Cholestyramine and colestipol: Reduced absorption of thiazides. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • KuetiapinantipsikotikModerat

    Quetiapine should be used with particular caution in patients with known cardiovascular disease (history of myocardial infarction or ischemic heart disease, heart failure, or conduction abnormalities), cerebrovascular disease, or conditions which would predispose patients to hypotension (dehydration, hypovolemia, and treatment with antihypertensive medications). (label Kuetiapin, Peringatan dan perhatian)

  • Kuinapril dan hidroklorotiazidpenghambat ACEModerat

    The thiazide component of quinapril and hydrochlorothiazide tablets may potentiate the action of other antihypertensive drugs, especially ganglionic or peripheral adrenergic- blocking drugs. (label Kuinapril dan hidroklorotiazid, Peringatan)

  • KuinidinantiaritmiaModerat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • KuininantimalariaModerat

    Although clinical drug interaction studies have not been performed, antimalarial doses (greater than or equal to 600 mg) of quinine may inhibit the metabolism of other drugs that are CYP2D6 substrates (e.g., flecainide, debrisoquine, dextromethorphan, metoprolol, paroxetine ). (label Kuinin, Interaksi obat)

  • LakosamidantikonvulsanModerat

    VIMPAT should also be used with caution in patients on concomitant medications that affect cardiac conduction, including sodium channel blockers, beta-blockers, calcium channel blockers, potassium channel blockers, and medications that prolong the PR interval [see Drug Interactions (7.2) ] . (label Lakosamid, Peringatan dan perhatian)

  • LanreotidModerat

    Bradycardia-Inducing Drugs (e.g., beta-blockers) : Lanreotide Injection may decrease heart rate. (label Lanreotid, Interaksi obat)

  • Lansoprazolpenghambat pompa protonModerat

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions (6.2) ] . (label Lansoprazol, Peringatan dan perhatian)

  • Patients also taking beta blockers, or those with underlying cardiac comorbidities and/or advanced liver disease, may be at increased risk for symptomatic bradycardia with coadministration of amiodarone. (label Ledipasvir dan sofosbuvir, Peringatan dan perhatian)

  • LevomilnasipranSNRIModerat

    Also, patients taking diuretics or who are otherwise volume depleted can be at greater risk. (label Levomilnasipran, Peringatan dan perhatian)

  • LevorfanolopioidModerat

    Diuretics Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (label Levorfanol, Interaksi obat)

  • Levosalbutamolagonis beta-adrenergikModerat

    Because beta1-selectivity is not absolute, use the lowest possible dose of metoprolol tartrate and have bronchodilators (e.g., beta 2 -agonists) readily available or administered concomitantly . (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Levotiroksinhormon tiroidModerat

    Drug or Drug Class Effect Beta-adrenergic antagonists e.g., Propranolol > 160 mg/day) In patients treated with large doses of propranolol (> 160 mg/day), T 3 and T 4 levels change slightly, TSH levels remain normal, and patients are clinically euthyroid. (label Levotiroksin, Interaksi obat)

  • Lidokain dan epinefrinanestetik lokalModerat

    Patients may be unresponsive to the usual doses of epinephrine used to treat allergic reaction. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Linagliptinpenghambat DPP-4Moderat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Linagliptin dan metforminpenghambat DPP-4Moderat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • LinezolidantibiotikModerat

    Catecholamine-depleting drugs (e.g., MAO inhibitors): Hypotension, bradycardia. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Liotironinhormon tiroidModerat

    Drug or Drug Class Effect Beta-adrenergic antagonists (e.g., Propranolol >160 mg/day) In patients treated with large doses of propranolol (>160 mg/day), T3 and T4 levels change, TSH levels remain normal, and patients are clinically euthyroid. (label Liotironin, Interaksi obat)

  • Liraglutidagonis reseptor GLP-1Moderat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Lisinoprilpenghambat ACEModerat

    Patients at risk of excessive hypotension include those with the following conditions or characteristics: heart failure with systolic blood pressure below 100 mmHg, ischemic heart disease, cerebrovascular disease, hyponatremia, high dose diuretic therapy, renal dialysis, or severe volume and/or salt depletion of any etiology. (label Lisinopril, Peringatan dan perhatian)

  • Lisinopril dan hidroklorotiazidpenghambat ACEModerat

    When a diuretic is added to the therapy of a patient receiving lisinopril, an additional antihypertensive effect is usually observed (see DOSAGE AND ADMINISTRATION ). (label Lisinopril dan hidroklorotiazid, Interaksi obat)

  • Litiumobat serotonergikModerat

    Lithium: Risk of lithium toxicity. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Lopinavir dan ritonavirantiretroviralModerat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Losartanpenghambat reseptor angiotensin II (ARB)Moderat

    Hypotension in Volume- or Salt-Depleted Patients In patients with an activated renin-angiotensin system, such as volume- or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may occur after initiation of treatment with COZAAR. (label Losartan, Peringatan dan perhatian)

  • LumateperonantipsikotikModerat

    Orthostatic vital signs should be monitored in patients who are vulnerable to hypotension (e.g., elderly patients, patients with dehydration, hypovolemia, and concomitant treatment with antihypertensive drugs), patients with known cardiovascular disease (history of myocardial infarction, ischemic heart disease, heart failure, or conduction abnormalities), and patients… (label Lumateperon, Peringatan dan perhatian)

  • LurasidonantipsikotikModerat

    Patients at increased risk of these adverse reactions or at increased risk of developing complications from hypotension include those with dehydration, hypovolemia, treatment with antihypertensive medication, history of cardiovascular disease (e.g., heart failure, myocardial infarction, ischemia, or conduction abnormalities), history of cerebrovascular disease,… (label Lurasidon, Peringatan dan perhatian)

  • MeflokuinantimalariaModerat

    There is one report of cardiopulmonary arrest, with full recovery, in a patient who was taking a beta blocker (propranolol) (see PRECAUTIONS, Cardiac Effects ). (label Meflokuin, Interaksi obat)

  • MekamilaminantihipertensiModerat

    The action of Mecamylamine HCl may be potentiated by anesthesia, other antihypertensive drugs and alcohol. (label Mekamilamin, Interaksi obat)

  • MeloksikamOAINSModerat

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • MetadonopioidModerat

    Closely monitor patients with risk factors for development of prolonged QT interval (e.g., cardiac hypertrophy, concomitant diuretic use, hypokalemia, hypomagnesemia), a history of cardiac conduction abnormalities, and those taking medications affecting cardiac conduction. (label Metadon, Peringatan dan perhatian)

  • MetforminbiguanidModerat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Metilen birupenghambat MAOModerat

    Catecholamine-depleting drugs (e.g., MAO inhibitors): Hypotension, bradycardia. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Metilergometrinalkaloid ergotModerat

    Beta-blockers Caution should be exercised when methylergonovine maleate is used concurrently with beta-blockers. (label Metilergometrin, Interaksi obat)

  • Metilfenidatstimulan SSPModerat

    Antihypertensive Drugs: Monitor blood pressure. (label Metilfenidat, Interaksi obat)

  • Metoprololpenyekat betaModerat

    If such symptoms occur, increase diuretics and restore clinical stability before advancing the dose of Metoprolol Tartrate Tablets [see Dosage and Administration (2) ]. (label Metoprolol, Peringatan dan perhatian)

  • MiglitolantidiabetesModerat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • MilnasipranSNRIModerat

    Also, patients taking diuretics or who are otherwise volume-depleted may be at greater risk [see Geriatric Use ( 8.5 )] . (label Milnasipran, Peringatan dan perhatian)

  • Mirabegronagonis beta-adrenergikModerat

    Because beta1-selectivity is not absolute, use the lowest possible dose of metoprolol tartrate and have bronchodilators (e.g., beta 2 -agonists) readily available or administered concomitantly . (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • MirtazapinantidepresanModerat

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia [see Use in Specific Populations (8.5) ] . (label Mirtazapin, Peringatan dan perhatian)

  • Modafinilstimulan SSPModerat

    However, a retrospective analysis of the use of antihypertensive medication in these studies showed that a greater proportion of patients on PROVIGIL required new or increased use of antihypertensive medications (2.4%) compared to patients on placebo (0.7%). (label Modafinil, Peringatan dan perhatian)

  • Moeksiprilpenghambat ACEModerat

    Symptomatic hypotension is most likely to occur in patients who have been salt- and volume- depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting. (label Moeksipril, Peringatan)

  • MorfinopioidModerat

    Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (label Morfin, Interaksi obat)

  • Patients receiving concomitant negative chronotropic drugs (e.g., beta blockers) may be more at risk for hypotension in case of hypersensitivity reaction. (label Motiksafortid, Peringatan dan perhatian)

  • NabumetonOAINSModerat

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Nadololpenyekat betaModerat

    Although beta-blockers should be avoided in overt congestive heart failure, if necessary, they can be used with caution in patients with a history of failure who are well-compensated, usually with digitalis and diuretics. (label Nadolol, Peringatan)

  • Nafsilinantibiotik penisilinModerat

    Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • NalbufinopioidModerat

    Diuretics Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (label Nalbufin, Interaksi obat)

  • Naltrekson dan bupropionantagonis opioidModerat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • NaproksenOAINSModerat

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • NateglinidmeglitinidModerat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Increase the dose of diuretics as needed [see Adverse Reactions (6) ] . (label Natrium zirkonium siklosilikat, Peringatan dan perhatian)

  • NiasinModerat

    Antihypertensive Therapy Niacin may potentiate the effects of ganglionic blocking agents and vasoactive drugs resulting in postural hypotension. (label Niasin, Interaksi obat)

  • Nifedipinpenghambat kanal kalsium dihidropiridinModerat

    Digitalis, Clonidine, and Calcium Channel Blockers: Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Nikardipinpenghambat kanal kalsium dihidropiridinModerat

    Digitalis, Clonidine, and Calcium Channel Blockers: Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Nilotinibobat yang memperpanjang interval QTModerat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Nimodipinpenghambat kanal kalsium dihidropiridinModerat

    Digitalis, Clonidine, and Calcium Channel Blockers: Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Nisoldipinpenghambat kanal kalsium dihidropiridinModerat

    Digitalis, Clonidine, and Calcium Channel Blockers: Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • NitrogliserinnitratModerat

    Antihypertensives: Possible additive hypotensive effects. (label Nitrogliserin, Interaksi obat)

  • OksaprozinOAINSModerat

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Oksasilinantibiotik penisilinModerat

    Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • OksikodonopioidModerat

    Examples: cyclobenzaprine, metaxalone Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (label Oksikodon, Interaksi obat)

  • Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (label Oksikodon dan parasetamol, Interaksi obat)

  • OksimetazolindekongestanModerat

    Caution in using drugs such as beta-blockers, anti-hypertensives, and/or cardiac glycosides is advised. (label Oksimetazolin, Interaksi obat)

  • OksimorfonopioidModerat

    Examples: butorphanol, nalbuphine, pentazocine, buprenorphine Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (label Oksimorfon, Interaksi obat)

  • OktreotidModerat

    Dosage adjustments of concomitantly used drugs that have bradycardia effects (i.e. beta-blockers) may be necessary [see Drug Interactions (‎7.2) ]. (label Oktreotid, Peringatan dan perhatian)

  • OlanzapinantipsikotikModerat

    …of myocardial infarction or ischemia, heart failure, or conduction abnormalities), cerebrovascular disease, and conditions which would predispose patients to hypotension (dehydration, hypovolemia, and treatment with antihypertensive medications) where the occurrence of syncope, or hypotension and/or bradycardia might put the patient at increased medical risk. (label Olanzapin, Peringatan dan perhatian)

  • Olanzapin dan fluoksetinantipsikotikModerat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • OliseridinopioidModerat

    Examples: cyclobenzaprine, metaxalone Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (label Oliseridin, Interaksi obat)

  • Olmesartanpenghambat reseptor angiotensin II (ARB)Moderat

    Hypotension in Volume- or Salt-Depleted Patients In patients with an activated renin-angiotensin-aldosterone system, such as volume- and/or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may be anticipated after initiation of treatment with Benicar. (label Olmesartan, Peringatan dan perhatian)

  • Olmesartan, amlodipin, dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Moderat

    Digitalis, Clonidine, and Calcium Channel Blockers: Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Omeprazolpenghambat pompa protonModerat

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions ( 6.2 )] . (label Omeprazol, Peringatan dan perhatian)

  • Omeprazol dan natrium bikarbonatpenghambat pompa protonModerat

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions ( 6.2 )] . (label Omeprazol dan natrium bikarbonat, Peringatan dan perhatian)

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • PaliperidonantipsikotikModerat

    Use ERZOFRI with caution in patients with known cardiovascular disease (e.g., heart failure, history of myocardial infarction or ischemia, conduction abnormalities), cerebrovascular disease, or conditions that predispose the patient to hypotension (e.g., dehydration, hypovolemia, and treatment with antihypertensive medications). (label Paliperidon, Peringatan dan perhatian)

  • Pantoprazolpenghambat pompa protonModerat

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions (6.2) ]. (label Pantoprazol, Peringatan dan perhatian)

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Diuretics Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (label Parasetamol dan kodein, Interaksi obat)

  • Parikalsitolanalog vitamin DModerat

    The risk may be increased when Paricalcitol Injection is used concomitantly with high dose calcium preparations, thiazide diuretics, or vitamin D compounds. (label Parikalsitol, Peringatan dan perhatian)

  • ParoksetinSSRIModerat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • PasireotidModerat

    Adjustments in the dose of drugs known to slow the heart rate (e.g., beta-blockers, calcium channel blockers) and correction of electrolyte disturbances may be necessary when initiating or during the course of SIGNIFOR LAR treatment. (label Pasireotid, Peringatan dan perhatian)

  • PazopanibModerat

    Monitor blood pressure as clinically indicated and initiate and adjust antihypertensive therapy as appropriate. (label Pazopanib, Peringatan dan perhatian)

  • Diuretics Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (label Pentazosin dan nalokson, Interaksi obat)

  • PentoksifilinmetilxantinModerat

    Small decreases in blood pressure have been observed in some patients treated with pentoxifylline extended-release tablets; periodic systemic blood pressure monitoring is recommended for patients receiving concomitant antihypertensive therapy. (label Pentoksifilin, Interaksi obat)

  • Perindoprilpenghambat ACEModerat

    Symptomatic hypotension is most likely to occur in patients who have been volume or salt-depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea or vomiting [see Dosage and Administration (2.1) ] . (label Perindopril, Peringatan dan perhatian)

  • PetidinopioidModerat

    Examples: Cyclobenzaprine, metaxalone Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (label Petidin, Interaksi obat)

  • Pilokarpinagonis kolinergikModerat

    Drug Interactions Pilocarpine should be administered with caution to patients taking beta-adrenergic antagonists because of the possibility of conduction disturbances. (label Pilokarpin, Interaksi obat)

  • Pindololpenyekat betaModerat

    Although beta-blockers should be avoided in overt congestive heart failure, if necessary, pindolol tablets can be used with caution in patients with a history of failure who are well-compensated, usually with digitalis and diuretics. (label Pindolol, Peringatan)

  • PioglitazontiazolidindionModerat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Pioglitazon dan glimepiridtiazolidindionModerat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Pioglitazon dan metformintiazolidindionModerat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Piperasilin dan tazobaktamantibiotik penisilinModerat

    Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Piridostigminpenghambat kolinesteraseModerat

    Use with caution in persons with increased risk of anticholinergic reactions, such as persons with bronchial asthma, chronic obstructive pulmonary disease, bradycardia, cardiac arrhythmias, beta blocker treatment (increased risk of anticholinergic reactions). (label Piridostigmin, Peringatan dan perhatian)

  • PiroksikamOAINSModerat

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • PonesimodimunosupresanModerat

    Experience with PONVORY is limited in patients receiving concurrent therapy with drugs that decrease heart rate (e.g., beta-blockers, non-dihydropyridine calcium channel blockers - diltiazem and verapamil, and other drugs that may decrease heart rate such as digoxin). (label Ponesimod, Peringatan dan perhatian)

  • Prazosinpenyekat alfaModerat

    Syncopal episodes have usually occurred within 30 to 90 minutes of the initial dose of the drug; occasionally, they have been reported in association with rapid dosage increases or the introduction of another antihypertensive drug into the regimen of a patient taking high doses of prazosin hydrochloride capsules. (label Prazosin, Peringatan)

  • Prilokain dan epinefrinanestetik lokalModerat

    Patients may be unresponsive to the usual doses of epinephrine used to treat allergic reaction. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • ProklorperazinantipsikotikModerat

    Thiazide diuretics may accentuate the orthostatic hypotension that may occur with phenothiazines. (label Proklorperazin, Perhatian)

  • Diuretics : Codeine may reduce the efficacy of diuretics. (label Prometazin dan kodein, Interaksi obat)

  • PropafenonantiaritmiaModerat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Propiltiourasilobat antitiroidModerat

    Beta-adrenergic blocking agents: Hyperthyroidism may cause an increased clearance of beta blockers with a high extraction ratio. (label Propiltiourasil, Interaksi obat)

  • Rabeprazolpenghambat pompa protonModerat

    For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically [see Adverse Reactions (6.2) ]. (label Rabeprazol, Peringatan dan perhatian)

  • Ramiprilpenghambat ACEModerat

    Experience with another ACE inhibitor suggests that these increases would be reversible upon discontinuation of ramipril and/or diuretic therapy. (label Ramipril, Peringatan dan perhatian)

  • Ranolazinobat yang memperpanjang interval QTModerat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Rasagilinpenghambat MAOModerat

    Catecholamine-depleting drugs (e.g., MAO inhibitors): Hypotension, bradycardia. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • RifampisinantibiotikModerat

    Decrease exposure Beta-blockers Metoprolol Decrease exposure Propranolol Decrease exposure Benzodiazepines Diazepam , Administered with rifampin 1200 mg daily Decrease exposure Benzodiazepine-related drugs Zopiclone Decrease AUC by 82% Zolpidem Decrease AUC by 73% Calcium Channel Blockers Diltiazem Decrease exposure Nifedipine Rifampin 1200 mg administered as… (label Rifampisin, Interaksi obat)

  • RifapentinantibiotikModerat

    …Anticonvulsants Phenytoin Antimalarials Quinine Azole Antifungals Fluconazole, itraconazole, ketoconazole Antipsychotics Haloperidol Barbiturates Phenobarbital Benzodiazepines Diazepam Beta-Blockers Propranolol Calcium Channel Blockers Diltiazem, nifedipine, verapamil Cardiac Glycoside Preparations Digoxin Corticosteroids Prednisone Fibrates Clofibrate Oral Hypoglycemics… (label Rifapentin, Interaksi obat)

  • RiosiguatvasodilatorModerat

    Consider the potential for symptomatic hypotension or ischemia in patients with hypovolemia, severe left ventricular outflow obstruction, resting hypotension, autonomic dysfunction, or concomitant treatment with antihypertensives or strong CYP and P-gp/BCRP inhibitors [see Drug Interactions (7.2) and Clinical Pharmacology (12.3) ] . (label Riosiguat, Peringatan dan perhatian)

  • RisperidonantipsikotikModerat

    Clinically significant hypotension has been observed with concomitant use of oral RISPERDAL and antihypertensive medication. (label Risperidon, Peringatan dan perhatian)

  • RitonavirantiretroviralModerat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • RizatriptantriptanModerat

    Nadolol/Metoprolol : In a drug interactions study, effects of multiple doses of nadolol 80 mg or metoprolol 100 mg every 12 hours on the pharmacokinetics of a single dose of 10 mg rizatriptan were evaluated in healthy subjects (n=12). (label Rizatriptan, Interaksi obat)

  • Rolapitantpenghambat CYP2D6Moderat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Ropivakainanestetik lokalModerat

    Patients on beta-blockers may not manifest changes in heart rate, but blood pressure monitoring can detect a rise in systolic blood pressure. (label Ropivakain, Peringatan dan perhatian)

  • Saksagliptinpenghambat DPP-4Moderat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Saksagliptin dan metforminpenghambat DPP-4Moderat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Sakubitril dan valsartanpenghambat reseptor angiotensin II (ARB)Moderat

    Patients with an activated renin-angiotensin system, such as volume- and/or salt-depleted patients (e.g., those being treated with high doses of diuretics), are at greater risk. (label Sakubitril dan valsartan, Peringatan dan perhatian)

  • Salbutamolagonis beta-adrenergikModerat

    Because beta1-selectivity is not absolute, use the lowest possible dose of metoprolol tartrate and have bronchodilators (e.g., beta 2 -agonists) readily available or administered concomitantly . (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Salmeterolagonis beta-adrenergikModerat

    Because beta1-selectivity is not absolute, use the lowest possible dose of metoprolol tartrate and have bronchodilators (e.g., beta 2 -agonists) readily available or administered concomitantly . (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • SalsalatOAINSModerat

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • SefepimsefalosporinModerat

    Diuretics: Nephrotoxicity has been reported with concomitant administration of cephalosporins with potent diuretics such as furosemide. (label Sefepim, Interaksi obat)

  • SeftazidimsefalosporinModerat

    Drug Interactions Nephrotoxicity has been reported following concomitant administration of cephalosporins with aminoglycoside antibacterial drugs or potent diuretics such as furosemide. (label Seftazidim, Interaksi obat)

  • Selegilinpenghambat MAOModerat

    Catecholamine-depleting drugs (e.g., MAO inhibitors): Hypotension, bradycardia. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • SelekoksibOAINSModerat

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Semaglutidagonis reseptor GLP-1Moderat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • SertralinSSRIModerat

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia with SSRIs [see Use in Specific Populations ( 8.5 )] . (label Sertralin, Peringatan dan perhatian)

  • Sevimelinagonis kolinergikModerat

    DRUG INTERACTIONS Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances. (label Sevimelin, Interaksi obat)

  • Siklobenzaprinpelemas ototModerat

    …concomitant use of TONMYA with: MAO inhibitors may be life-threatening [see Contraindications (4) ] , Alcohol, barbiturates, and other CNS depressants may increase the risk of adverse reactions associated with these drugs, Tramadol may increase the seizure risk, Guanethidine or other similar acting drugs may block the antihypertensive action of these drugs. (label Siklobenzaprin, Interaksi obat)

  • SiklofosfamidimunosupresanModerat

    …inhibitors: ACE inhibitors can cause leukopenia. ● Natalizumab ● Paclitaxel: Increased hematotoxicity has been reported when cyclophosphamide was administered after paclitaxel infusion. ● Thiazide diuretics ● Zidovudine Increased cardiotoxicity ● Anthracyclines ● Cytarabine ● Pentostatin ● Radiation therapy of the cardiac region ● Trastuzumab Increased pulmonary toxicity… (label Siklofosfamid, Interaksi obat)

  • Sildenafilpenghambat PDE5Moderat

    Caution is advised when SILDENAFIL ORAL FILM is co-administered with alpha-blockers or antihypertensives. (label Sildenafil, Peringatan dan perhatian)

  • Silodosinpenyekat alfaModerat

    However, patients in the Phase 3 clinical studies taking concomitant antihypertensive medications with silodosin capsules did not experience a significant increase in the incidence of syncope, dizziness, or orthostasis. (label Silodosin, Peringatan dan perhatian)

  • Simetidinpenghambat H2Moderat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Sinakalsetpenghambat CYP2D6Moderat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Sitagliptinpenghambat DPP-4Moderat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Sitagliptin dan metforminpenghambat DPP-4Moderat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • SitalopramSSRIModerat

    Elderly patients, patients taking diuretics, and those who are volume depleted may be at greater risk for developing hyponatremia with SSRIs [see Use in Specific Populations ( 8.5 )] . (label Sitalopram, Peringatan dan perhatian)

  • Patients also taking beta blockers, or those with underlying cardiac comorbidities and/or advanced liver disease may be at increased risk for symptomatic bradycardia with coadministration of amiodarone. (label Sofosbuvir dan velpatasvir, Peringatan dan perhatian)

  • SorafenibModerat

    Consider temporary or permanent discontinuation for severe or persistent hypertension despite antihypertensive therapy. (label Sorafenib, Peringatan dan perhatian)

  • Sotalolpenyekat betaModerat

    Special attention should be given to electrolyte and acid-base balance in patients experiencing severe or prolonged diarrhea or patients receiving concomitant diuretic drugs. (label Sotalol, Peringatan dan perhatian)

  • Spironolaktonantagonis aldosteronModerat

    If such symptoms occur, increase diuretics and restore clinical stability before advancing the dose of metoprolol. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Spironolakton dan hidroklorotiazidantagonis aldosteronModerat

    If such symptoms occur, increase diuretics and restore clinical stability before advancing the dose of metoprolol. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Suksinilkolinpenyekat neuromuskularModerat

    Prolonged Neuromuscular Block in Patients with Hypokalemia or Hypocalcemia Neuromuscular blockade may be prolonged in patients with hypokalemia (e.g., after severe vomiting, diarrhea, digitalisation and diuretic therapy) or hypocalcemia (e.g., after massive transfusions). (label Suksinilkolin, Peringatan dan perhatian)

  • SulindakOAINSModerat

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • SunitinibModerat

    Initiate and/or adjust antihypertensive therapy as appropriate. (label Sunitinib, Peringatan dan perhatian)

  • TakrolimusimunosupresanModerat

    • Hypertension: May require antihypertensive therapy; monitor relevant drug interactions. (label Takrolimus, Peringatan dan perhatian)

  • TapentadolopioidModerat

    …use of skeletal muscle relaxants and opioids, consider prescribing naloxone for the emergency treatment of opioid overdose [see Dosage and Administration (2.2) , Warnings and Precautions (5.2 , 5.3) ] Examples: cyclobenzaprine, metaxalone Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (label Tapentadol, Interaksi obat)

  • Tasimelteonsedatif-hipnotikModerat

    Beta-adrenergic Receptor Antagonists (e.g., acebutolol, metoprolol) Beta-adrenergic receptor antagonists have been shown to reduce the production of melatonin via specific inhibition of beta-1 adrenergic receptors. (label Tasimelteon, Interaksi obat)

  • Telmisartanpenghambat reseptor angiotensin II (ARB)Moderat

    Hypotension In patients with an activated renin-angiotensin system, such as volume- or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may occur after initiation of therapy with telmisartan tablets. (label Telmisartan, Peringatan dan perhatian)

  • Telmisartan dan amlodipinpenghambat reseptor angiotensin II (ARB)Moderat

    Digitalis, Clonidine, and Calcium Channel Blockers: Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • TeofilinmetilxantinModerat

    Because beta1-selectivity is not absolute, use the lowest possible dose of metoprolol tartrate and have bronchodilators (e.g., beta 2 -agonists) readily available or administered concomitantly . (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Terazosinpenyekat alfaModerat

    Risk of Hypotension with Concomitant Use of Other Antihypertensive Agents and Phospodiesterase Type 5 Inhibitors (PDE5-I): Concomitant administration of TEZRULY with antihypertensives or phosphodiesterase-5 (PDE-5) inhibitors can result in additive blood pressure lowering effects and symptomatic hypotension (5.3). (label Terazosin, Peringatan dan perhatian)

  • TerbinafinantijamurModerat

    CYP2D6 inhibitors: Increased metoprolol concentration. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Terbutalinagonis beta-adrenergikModerat

    Because beta1-selectivity is not absolute, use the lowest possible dose of metoprolol tartrate and have bronchodilators (e.g., beta 2 -agonists) readily available or administered concomitantly . (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • TestosteronandrogenModerat

    In patients with hypertension on antihypertensive therapy, TLANDO increased the mean systolic/diastolic BP by 4.8/1.6 mm Hg from baseline. [see Adverse Reactions ( 6.1 )] . (label Testosteron, Peringatan dan perhatian)

  • Tetrabenazinpenghambat VMAT2Moderat

    Drug Interactions with Metoprolol Catecholamine Depleting Drugs: The concomitant use of catecholamine-depleting drugs (e.g., reserpine, monoamine oxidase (MAO) inhibitors) with beta adrenergic blockers may have an additive affect and increase the risk of hypotension or bradycardia CYP2D6 Inhibitors: Drugs that are strong inhibitors of CYP2D6 such as quinidine,… (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Tiamazolobat antitiroidModerat

    …(oral): Due to potential inhibition of vitamin K activity by methimazole, the activity of oral anticoagulants (e.g., warfarin) may be increased; additional monitoring of PT/INR should be considered, especially before surgical procedures. β-adrenergic blocking agents: Hyperthyroidism may cause an increased clearance of beta blockers with a high extraction ratio. (label Tiamazol, Interaksi obat)

  • TiotropiumantikolinergikModerat

    Because beta1-selectivity is not absolute, use the lowest possible dose of metoprolol tartrate and have bronchodilators (e.g., beta 2 -agonists) readily available or administered concomitantly . (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Tirzepatidagonis reseptor GLP-1Moderat

    Antidiabetic drugs: Dosage adjustment may be required. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • TobramisinaminoglikosidaModerat

    Some diuretics can enhance aminoglycoside toxicity by altering antibiotic concentrations in serum and tissue. (label Tobramisin, Interaksi obat)

  • TolmetinOAINSModerat

    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Reduced diuretic, natriuretic, and antihypertensive effects of diuretics. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • TolvaptanModerat

    Co-administration of diuretics also increases the risk of too rapid correction of serum sodium and such patients should undergo close monitoring of serum sodium. (label Tolvaptan, Peringatan dan perhatian)

  • TopiramatantikonvulsanModerat

    Hydrochlorothiazide (HCTZ) Topiramate C max and AUC increased when HCTZ was added to immediate-release topiramate. (label Topiramat, Interaksi obat)

  • Torasemiddiuretik loopModerat

    If such symptoms occur, increase diuretics and restore clinical stability before advancing the dose of metoprolol. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Toremifenmodulator reseptor estrogen selektifModerat

    Drugs that decrease renal calcium excretion, e.g., thiazide diuretics, may increase the risk of hypercalcemia in patients receiving FARESTON. (label Toremifen, Interaksi obat)

  • TramadolopioidModerat

    Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (label Tramadol, Interaksi obat)

  • Diuretics Clinical Impact: Opioids can reduce the efficacy of diuretics by inducing the release of antidiuretic hormone. (label Tramadol dan parasetamol, Interaksi obat)

  • Trandolaprilpenghambat ACEModerat

    Symptomatic hypotension is most likely to occur in patients who have been salt- or volume-depleted as a result of prolonged treatment with diuretics, dietary salt restriction, dialysis, diarrhea, or vomiting. (label Trandolapril, Peringatan)

  • TrazodonantidepresanModerat

    Concomitant use with an antihypertensive may require a reduction in the dose of the antihypertensive drug. (label Trazodon, Peringatan dan perhatian)

  • Triamterendiuretik hemat kaliumModerat

    If such symptoms occur, increase diuretics and restore clinical stability before advancing the dose of metoprolol. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Triamteren dan hidroklorotiaziddiuretik hemat kaliumModerat

    If such symptoms occur, increase diuretics and restore clinical stability before advancing the dose of metoprolol. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • TrifluoperazinantipsikotikModerat

    Thiazide diuretics may accentuate the orthostatic hypotension that may occur with phenothiazines. (label Trifluoperazin, Perhatian)

  • UmeklidiniumantikolinergikModerat

    Because beta1-selectivity is not absolute, use the lowest possible dose of metoprolol tartrate and have bronchodilators (e.g., beta 2 -agonists) readily available or administered concomitantly . (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Umeklidinium dan vilanterolantikolinergikModerat

    Because beta1-selectivity is not absolute, use the lowest possible dose of metoprolol tartrate and have bronchodilators (e.g., beta 2 -agonists) readily available or administered concomitantly . (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Valbenazinpenghambat VMAT2Moderat

    Drug Interactions with Metoprolol Catecholamine Depleting Drugs: The concomitant use of catecholamine-depleting drugs (e.g., reserpine, monoamine oxidase (MAO) inhibitors) with beta adrenergic blockers may have an additive affect and increase the risk of hypotension or bradycardia CYP2D6 Inhibitors: Drugs that are strong inhibitors of CYP2D6 such as quinidine,… (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Valsartanpenghambat reseptor angiotensin II (ARB)Moderat

    In patients with an activated renin-angiotensin system, such as volume- and/or salt-depleted patients receiving high doses of diuretics, symptomatic hypotension may occur. (label Valsartan, Peringatan dan perhatian)

  • Vardenafilpenghambat PDE5Moderat

    Vardenafil hydrochloride tablets can potentiate the hypotensive effects of nitrates, alpha- blockers, and antihypertensives. (label Vardenafil, Interaksi obat)

  • VenlafaksinSNRIModerat

    Caution should be exercised with co-administration of venlafaxine and metoprolol. (label Venlafaksin, Interaksi obat)

  • Verapamilpenghambat kanal kalsiumModerat

    Digitalis, Clonidine, and Calcium Channel Blockers: Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate. (label Metoprolol dan hidroklorotiazid, Interaksi obat)

  • Vibegronagonis beta-adrenergikModerat

    Because beta1-selectivity is not absolute, use the lowest possible dose of metoprolol tartrate and have bronchodilators (e.g., beta 2 -agonists) readily available or administered concomitantly . (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • VilazodonSSRIModerat

    Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia with SSRIs and SNRIs [see Use in Specific Populations ( 8.5 )] . (label Vilazodon, Peringatan dan perhatian)

  • Vitamin DVitamin dan mineralModerat

    Diuretik tiazid mengurangi ekskresi kalsium; bila dikombinasikan dengan suplemen vitamin D dan kalsium, hal ini dapat berujung pada hiperkalsemia, terutama pada orang lanjut usia. (NIH Office of Dietary Supplements, Vitamin D)

  • VortioksetinantidepresanModerat

    Also, patients taking diuretics or who are otherwise volume-depleted can be at greater risk. (label Vortioksetin, Peringatan dan perhatian)

  • Zileutonpenghambat CYP1A2Moderat

    Zileuton increases propranolol levels and beta-blocker activity. (label Zileuton, Interaksi obat)

  • ZiprasidonantipsikotikModerat

    Hypokalemia may result from diuretic therapy, diarrhea, and other causes. (label Ziprasidon, Peringatan dan perhatian)

Penyebutan minor (57)

  • AdenosinantiaritmiaMinor

    Effects of Adenosine on Other Drugs Adenosine injection has been given with other cardioactive drugs (such as beta adrenergic blocking agents, cardiac glycosides, and calcium channel blockers) without apparent adverse interactions, but its effectiveness with these agents has not been systematically evaluated. (label Adenosin, Interaksi obat)

  • AmantadinantikolinergikMinor

    Coadministration of 1 Dyazide (triamterene/hydrochlorothiazide) resulted in a higher plasma amantadine hydrochloride concentration in a 61-year old man receiving amantadine hydrochloride 100 mg TID for Parkinson's disease. (label Amantadin, Interaksi obat)

  • Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure. (label Ambrisentan, Peringatan dan perhatian)

  • Betaksololpenyekat betaMinor

    Because of its relative beta 1 cardio-selectivity, however, metoprolol tartrate may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Bosentanpenginduksi CYP3A4Minor

    Patients required intervention with a diuretic, fluid management, or hospitalization for decompensating heart failure. (label Bosentan, Peringatan dan perhatian)

  • ButorfanolopioidMinor

    In such cases, butorphanol should be discontinued and the hypertension treated with antihypertensive drugs. (label Butorfanol, Peringatan)

  • Fluid retention events were typically managed by supportive care measures that may include diuretics or short courses of steroids. (label Dasatinib, Peringatan dan perhatian)

  • Dekstroamfetaminstimulan SSPMinor

    Examples of alkalinizing agents include gastrointestinal alkalinizing agents (e.g., sodium bicarbonate) and urinary alkalinizing agents (e.g. acetazolamide, some thiazides). (label Dekstroamfetamin, Interaksi obat)

  • Desogestrel dan etinilestradiolkontrasepsi oralMinor

    If other contraceptive methods are not suitable, hormonal contraceptive therapy may continue combined with antihypertensive therapy. (label Desogestrel dan etinilestradiol, Peringatan)

  • Doksazosinpenyekat alfaMinor

    Pheochromocytoma: First initiate therapy with an alpha blocker. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Patients developing peripheral edema may be treated with standard measures, e.g., salt restriction, oral diuretic(s). (label Dosetaksel, Peringatan dan perhatian)

  • Dutasterid dan tamsulosinpenghambat 5-alfa reduktaseMinor

    Pheochromocytoma: First initiate therapy with an alpha blocker. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • EfedrinsimpatomimetikMinor

    Examples: α-adrenergic antagonists, β-adrenergic receptor antagonists, reserpine, quinidine, mephentermine Other Drug Interactions G u anethidine C linical Impact: Ephedrine may inhibit the neuron blockage produced by guanethidine, resulting in loss of antihypertensive effectiveness. (label Efedrin, Interaksi obat)

  • Because of its relative beta 1 cardio-selectivity, however, metoprolol tartrate may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • In addition to discontinuation of the drug, diuretic therapy may be required. (label Estrogen teresterifikasi dan metiltestosteron, Peringatan)

  • Febuksostatpenghambat xantin oksidaseMinor

    In Vivo Drug Interaction Studies Based on drug interaction studies in healthy patients, ULORIC does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine [see Clinical Pharmacology (12.3) ]. (label Febuksostat, Interaksi obat)

  • Fenoksibenzaminpenyekat alfaMinor

    Pheochromocytoma: First initiate therapy with an alpha blocker. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Fentolaminpenyekat alfaMinor

    Pheochromocytoma: First initiate therapy with an alpha blocker. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Finasteridpenghambat 5-alfa reduktaseMinor

    …PROSCAR was concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, α-blockers, angiotensin-converting enzyme (ACE) inhibitors, analgesics, anti-convulsants, beta-adrenergic blocking agents, diuretics, calcium channel blockers, cardiac nitrates, HMG-CoA reductase inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines,… (label Finasterid, Interaksi obat)

  • FingolimodimunosupresanMinor

    Drugs That Slow Heart Rate or Atrioventricular Conduction (e.g., beta blockers or diltiazem) Experience with GILENYA in patients receiving concurrent therapy with drugs that slow the heart rate or AV conduction (e.g., beta blockers, digoxin, or heart rate-slowing calcium channel blockers, such as diltiazem or verapamil) is limited. (label Fingolimod, Interaksi obat)

  • Guanfasinagonis alfa-adrenergikMinor

    Because of its relative beta 1 cardio-selectivity, however, metoprolol tartrate may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • HidralazinvasodilatorMinor

    Because of its relative beta 1 cardio-selectivity, however, metoprolol tartrate may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Hidroklorotiaziddiuretik tiazidMinor

    Because of its relative beta 1 cardio-selectivity, however, metoprolol tartrate may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • ACE Inhibitors FIRAZYR is a bradykinin B2 receptor antagonist and thereby has the potential to have a pharmacodynamic interaction with ACE inhibitors where FIRAZYR may attenuate the antihypertensive effect of ACE inhibitors. (label Ikatibant, Interaksi obat)

  • Irbesartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Minor

    Because of its relative beta 1 cardio-selectivity, however, metoprolol tartrate may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Because of its relative beta 1 cardio-selectivity, however, metoprolol tartrate may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • KaliumVitamin dan mineralMinor

    Diuretik loop dan diuretik tiazid meningkatkan kehilangan kalium; suplementasi kadang diresepkan bersamanya. (NIH Office of Dietary Supplements, Potassium)

  • KalsiumVitamin dan mineralMinor

    Diuretik tiazid mengurangi ekskresi kalsium, sehingga asupan kalsium yang tinggi dapat menaikkan kalsium darah. (NIH Office of Dietary Supplements, Calcium)

  • Drugs that may cause hypercalcemia: Vitamin D, vitamin A, thiazide diuretics, estrogen, calcipotriene and teriparatide administration may cause hypercalcemia. (label Kalsium glukonat, Interaksi obat)

  • Kandesartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Minor

    Because of its relative beta 1 cardio-selectivity, however, metoprolol tartrate may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Acthar Gel may accentuate the electrolyte loss associated with diuretic therapy. (label Kortikotropin, Interaksi obat)

  • Labetalolpenyekat betaMinor

    Pheochromocytoma: First initiate therapy with an alpha blocker. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Levotiroksin dan liotironinhormon tiroidMinor

    Abrupt withdrawal in thyrotoxicosis might precipitate a thyroid storm. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Lofeksidinagonis alfa-adrenergikMinor

    Because of its relative beta 1 cardio-selectivity, however, metoprolol tartrate may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Losartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Minor

    Because of its relative beta 1 cardio-selectivity, however, metoprolol tartrate may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • MagnesiumVitamin dan mineralMinor

    Penggunaan jangka panjang diuretik loop dan diuretik tiazid meningkatkan kehilangan magnesium melalui urine. (NIH Office of Dietary Supplements, Magnesium)

  • Postmarketing cases of edema and fluid retention occurring within weeks of starting OPSUMIT, some requiring intervention with a diuretic or hospitalization for decompensated heart failure, have been reported [see Adverse Reactions (6.2) ] . (label Masitentan, Peringatan dan perhatian)

  • MeksiletinantiaritmiaMinor

    In a large compassionate use program mexiletine has been used concurrently with commonly employed antianginal, antihypertensive, and anticoagulant drugs without observed interactions. (label Meksiletin, Interaksi obat)

  • MetildopaantihipertensiMinor

    Because of its relative beta 1 cardio-selectivity, however, metoprolol tartrate may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • MetilprednisolonkortikosteroidMinor

    Amphotericin B injection and potassium-depleting agents : When corticosteroids are administered concomitantly with potassium-depleting agents (e.g., amphotericin B, diuretics), patients should be observed closely for development of hypokalemia. (label Metilprednisolon, Interaksi obat)

  • MetiltestosteronandrogenMinor

    In addition to discontinuation of the drug, diuretic therapy may be required. (label Metiltestosteron, Peringatan)

  • Milrinonpenghambat PDE3Minor

    …been observed in limited experience with patients in whom milrinone was used concurrently with the following drugs: digitalis glycosides; lidocaine, quinidine; hydralazine, prazosin; isosorbide dinitrate, nitroglycerin; chlorthalidone, furosemide, hydrochlorothiazide, spironolactone; captopril; heparin, warfarin, diazepam, insulin; and potassium supplements. (label Milrinon, Interaksi obat)

  • NitroprusidvasodilatorMinor

    Because of its relative beta 1 cardio-selectivity, however, metoprolol tartrate may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Nortriptilinantidepresan trisiklikMinor

    The antihypertensive action of guanethidine and similar agents may be blocked. (label Nortriptilin, Peringatan)

  • Olmesartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Minor

    Because of its relative beta 1 cardio-selectivity, however, metoprolol tartrate may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • PerfenazinantipsikotikMinor

    Drug Interactions Metabolism of a number of medications, including antipsychotics, antidepressants, β-blockers, and antiarrhythmics, occurs through the cytochrome P450 2D6 isoenzyme (debrisoquine hydroxylase). (label Perfenazin, Interaksi obat)

  • PrednisolonkortikosteroidMinor

    Potassium-depleting agents (e.g., diuretics, Amphotericin B): When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (label Prednisolon, Interaksi obat)

  • PrednisonkortikosteroidMinor

    Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) When corticosteroids are administered concomitantly with potassium-depleting agents, patients should be observed closely for development of hypokalemia. (label Prednison, Interaksi obat)

  • Propranololpenyekat betaMinor

    Because of its relative beta 1 cardio-selectivity, however, metoprolol tartrate may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Protriptilinantidepresan trisiklikMinor

    Protriptyline may block the antihypertensive effect of guanethidine or similarly acting compounds. (label Protriptilin, Peringatan)

  • Tamsulosinpenyekat alfaMinor

    Pheochromocytoma: First initiate therapy with an alpha blocker. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Telmisartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Minor

    Because of its relative beta 1 cardio-selectivity, however, metoprolol tartrate may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Teriparatidhormon tiroidMinor

    Abrupt withdrawal in thyrotoxicosis might precipitate a thyroid storm. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Tizanidinpelemas ototMinor

    Because of its relative beta 1 cardio-selectivity, however, metoprolol tartrate may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • TriamsinolonkortikosteroidMinor

    Amphotericin B injection and potassium-depleting agents: When corticosteroids are administered concomitantly with potassium-depleting agents ( i.e., amphotericin B, diuretics), patients should be observed closely for development of hypokalemia. (label Triamsinolon, Interaksi obat)

  • Valsartan dan hidroklorotiazidpenghambat reseptor angiotensin II (ARB)Minor

    Because of its relative beta 1 cardio-selectivity, however, metoprolol tartrate may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment. (label Metoprolol dan hidroklorotiazid, Peringatan dan perhatian)

  • Zink (seng)Vitamin dan mineralMinor

    Diuretik tiazid meningkatkan kehilangan zink melalui urine pada penggunaan jangka panjang. (NIH Office of Dietary Supplements, Zinc)

Tidak ada interaksi bermakna yang dilaporkan (4)

  • IbutilidantiaritmiaTanpa interaksi

    Beta-adrenergic blocking agents: Coadministration of beta-adrenergic blocking agents did not have any effect on either the safety or efficacy of ibutilide in the clinical trials. (label Ibutilid, Interaksi obat)

  • PamidronatbisfosfonatTanpa interaksi

    Loop Diuretics Concomitant administration of a loop diuretic had no effect on the calcium-lowering action of pamidronate disodium. (label Pamidronat, Interaksi obat)

  • Ropinirolagonis dopaminTanpa interaksi

    Commonly Administered Drugs: Population analysis showed that commonly administered drugs (e.g., selegiline, amantadine, tricyclic antidepressants, benzodiazepines, ibuprofen, thiazides, antihistamines, anticholinergics) did not affect the clearance of ropinirole. (label Ropinirol, Interaksi obat)

  • Sevelamerpengikat fosfatTanpa interaksi

    Table 5: Sevelamer Drug Interactions Oral drugs for which sevelamer did not alter the pharmacokinetics when administered concomitantly Digoxin Enalapril Iron Metoprolol Warfarin Oral drugs that have demonstrated interaction with sevelamer and are to be dosed separately from sevelamer carbonate Dosing Recommendations Ciprofloxacin Take at least 2 hours before… (label Sevelamer, Interaksi obat)

Periksa Metoprolol dan hidroklorotiazid terhadap semua yang Anda gunakan. Tambahkan seluruh daftar Anda; setiap pasangan diperiksa sekaligus.

Buka di pemeriksa

Bukan nasihat medis. Tingkat keparahan mencerminkan kata-kata dalam label, bukan keadaan Anda. Tanda “mayor” bisa merupakan hal yang rutin di bawah pengawasan, dan tanda “minor” bisa menjadi penting pada dosis tinggi. Tanyakan kepada apoteker.